GlassScriptPhysician profile
Jeremy Smitherman
NPI 1457507055
$11,247.25
in general payments reported to CMS, 2019-2025
23 companies · $1,261 in 2025
The $1,261 reported for 2025 was more than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,478 · 2020: $1,848 · 2021: $3,195 · 2022: $1,718 · 2023: $732 · 2024: $1,015 · 2025: $1,261.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,008.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,008.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $5,098.36 | 2019-2025 | General - Pain Management, Wavewriter Alpha Prime 16, Intracept |
| Abbott Laboratories | $2,452.77 | 2020-2025 | Eterna |
| Zavation Medical Products, LLC | $1,250.00 | 2021 | |
| Nalu Medical, INC. | $633.64 | 2021-2023 | Nalu Neurostimulation System |
| Nevro Corp. | $533.87 | 2019-2024 | Senza |
| Medtronic, INC. | $290.03 | 2021-2025 | Intellis Adaptivestim |
| Globus Medical, INC. | $200.15 | 2025 | Senza, Vyrsa V1 |
| Si-Bone, INC. | $183.85 | 2020-2025 | |
| Painteq LLC | $101.76 | 2021 | |
| Vertos Medical, INC. | $88.36 | 2023-2024 | Mild Device Kit |
| Biotronik Nro, INC. | $70.85 | 2025 | Prospera |
| Avanos Medical | $58.75 | 2019-2025 | Standard Rf Disposables |
| Collegium Pharmaceutical, INC. | $49.60 | 2020-2024 | Xtampza |
| Eagle Pharmaceuticals, INC. | $49.42 | 2023 | |
| Baudax Bio INC. | $44.44 | 2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $29.56 | 2020 | |
| Foundation Fusion Solutions, LLC | $26.00 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $18.76 | 2022 | |
| Fidia Pharma USA INC. | $14.68 | 2020 | |
| Grt US Holding, INC. | $14.11 | 2020 | |
| Curonix LLC | $13.31 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Pfizer INC. | $12.92 | 2020 | |
| Nuvasive, INC. | $12.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeremy Smitherman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.